World Investment Advisors’s Coca-Cola Europacific Partners CCEP Stock Holding History

World Investment Advisors’s Portfolio CCEP Stock Details CCEP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,372	Closed	-$293K	–	1143
2025 Q1	$293K	Buy	+3,372	New	+$275K	0.01%	872

Other funds holding CCEP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

World Investment Advisors's CCEP Position: Q2 2025 in Review

World Investment Advisors sold out of Coca-Cola Europacific Partners (CCEP) in Q2 2025, closing a stake of 3,372 shares — an estimated $293K sold.

World Investment Advisors first reported a position in CCEP in Q1 2025 and held it in 1 quarter. The position peaked at $293K in Q1 2025. 544 funds tracked by Wall St. Rank hold CCEP as of Q2 2025.

World Investment Advisors reported no remaining Coca-Cola Europacific Partners position as of Q2 2025 after selling out during the quarter.
World Investment Advisors sold 3,372 Coca-Cola Europacific Partners shares in Q2 2025, an estimated $293K.
World Investment Advisors first reported a position in Coca-Cola Europacific Partners in Q1 2025 and held it in 1 quarter.
World Investment Advisors's Coca-Cola Europacific Partners position peaked at $293K in Q1 2025.
544 funds tracked by Wall St. Rank held Coca-Cola Europacific Partners as of Q2 2025.

Based on World Investment Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.